Standards and Guidelines
Visiopharm, a world leader in AI-driven precision pathology software, today announced that its existing portfolio of diagnostic apps have all been certified under the new In Vitro Diagnostic Regulation (IVDR). The major difference between...
February 2, 2022 -- Artemis DNA’s two facilities, in Irvine, California and Houston, Texas, are now both CLIA and CAP accredited. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high...
The four-year agreement is estimated to be worth £5 billion. A pool of 46 tech suppliers have been selected for the framework which provides digital document management tools and printing services to NHS organisations. The NHS London...
Aiforia announces the CE-IVD mark of its Aiforia® Clinical AI Model for Lung Cancer; PD-L1 for assisting pathologists in the fast and accurate primary diagnosis of lung cancer. This latest AI model expands Aiforia’s portfolio of clinical...
Regulator OKs DeepBio’s AI-based Prostate Cancer Pathology Di...
DeepBio said its DeepDx-Prostate Pro, an artificial intelligence (AI)-based pathology diagnosis assistance software, has received a Class 3 in-vitro diagnostic medical device from the Ministry of Food and Drug Safety. According to the...
Business Development Manager - Digital Pathology Apply Now! Job Facts At Roche, we believe it’s urgent to deliver medical solutions right now, even as we develop innovations for the future. We are passionate about transforming patients’...
